-
249 domestic pharmaceutical companies are listed in the "World's Top Thousands", and these 5 have outstanding performance
Time of Update: 2022-01-01
. A number of brokerage research reports believe that as Hengrui Pharmaceuticals continues to increase its international layout, it is expected to further expand the pipeline of innovative products and increase the company's performance in the future .
-
Among the 9 high-paying positions in the pharmaceutical industry, the fifth is a pharmaceutical representative...
Time of Update: 2022-01-01
This position needs to have a certain understanding of pharmaceutical policies and medicine, collect national drug administration information and policies, write application materials, organize and update drug research and development technology Guidance documents, sorting out company registration application materials, etc.
-
Naproxen Sodium Tablets, a subsidiary of Renfu Pharmaceutical Holdings, obtained the drug registration certificate
Time of Update: 2022-01-01
Yichang Renfu’s naproxen sodium tablets were approved by the FDA in August 2019, and the registration application for the drug was submitted to the National Medical Products Administration in November 2019 and was accepted.
-
Novartis' next-generation IgE antibody application for clinical application has received FDA breakthrough therapy designation
Time of Update: 2022-01-01
In a phase IIb (NCT02477332) dose exploratory study of patients with moderate to severe CSU, compared with Novartis’s previous generation IgE antibody Xolair (omalizumab) group, more people in the ligelizumab group had complete remission of urticaria (51 % vs.
-
Shandong Provincial Health Commission released a reference catalog of personalized service packages for family doctors signing services
Time of Update: 2022-01-01
On November 30, the Shandong Provincial Health and Health Commission issued the "Reference Catalogue of Personalized Service Packages for Contracting Family Doctors for Patients with COPD, Coronary Heart Disease, and Stroke (2021 Edition)".
Chronic disease has formulated specific projects for individualized contracted services by family doctors .
-
Well-known pharmaceutical company fined 32.07 million for adding extracts illegally
Time of Update: 2022-01-01
When Herentang Pharmaceutical produces the drug "Kangfuling Capsules", it illegally extracts the cork extract powder and adds it to ensure that the product content meets the standard requirements .
-
Amgen postpones the launch of Samsung's Enbrel biosimilar to 2029
Time of Update: 2022-01-01
According to the latest judgment, Samsung Bioepis will not be able to manufacture, sell or import Enbrel biosimilar drugs in the United States before 2029 .
-
Recently, there has been frequent cooperation between pharmaceutical companies in diagnosis
Time of Update: 2022-01-01
In addition, AstraZeneca also plans to apply the above-mentioned products developed in cooperation with Genetron Health to clinical trials involving customized solid tumor MRD detection in China .
-
GlaxoSmithKline/Vir monoclonal antibody sotrovimab is effective against key Omicron mutations
Time of Update: 2022-01-01
Compile | newbornOn December 2, GlaxoSmithKline (GSK) and Vir Biotech announced an update of a study on the preprinted website bioRxiv: Preclinical data showed that the monoclonal antibody sotrovimab targets the new Omicron SARS-CoV-2 variant ( B.
-
Industry Appeal: Incorporate online sales of drugs into the "Law Net" as soon as possible
Time of Update: 2022-01-01
. The author has learned that, in order to further regulate drug online sales activities and severely crack down on illegal drug online sales, many cities have already carried out special management work on drug online sales .
-
In 2022, the wave of layoffs among multinational pharmaceutical companies is expected to continue!
Time of Update: 2022-01-01
According to incomplete statistics in the industry, from January to November 2021, at least 28 multinational pharmaceutical companies have experienced layoffs, including Sanofi, Amgen, Gilead, Well-known large pharmaceutical companies such as Novartis, GlaxoSmithKline, Mylan, Gilead, Johnson & Johnson, and AstraZeneca .
-
Domestic pharmaceutical companies have been rejected for listing new drugs, and innovative R&D is not easy
Time of Update: 2022-01-01
Recently, Wanchun Medicine issued an announcement stating that the marketing application of Pranabrin for the treatment of chemotherapy-induced neutropenia (CIN) has received a complete response letter (CRL) from the US FDA .
-
A large number of pharmaceutical companies have unsatisfactory cross-border effects. How to solve the dilemma?
Time of Update: 2022-01-01
At present, in addition to North China Medicine, there are actually a large number of pharmaceutical companies in tea, daily necessities and other industries that are entering the market across the border .
-
The new year is approaching, and domestic and foreign pharmaceutical companies such as Novartis and Conba have dumped their assets!
Time of Update: 2022-01-01
through public listing in Zhejiang Equity Exchange; on September 23, the company announced that it intends to transfer its holdings of Jiangxi Zhenshiming Pharmaceutical Co.
-
A pharmacy sells inferior drugs without fines of 100,000
Time of Update: 2022-01-01
Based on the above facts, in accordance with the relevant penal provisions of the "Regulations on the Implementation of the Drug Administration Law", the regulatory authorities impose the following penalties on pharmacies:Ordered to correct relevant illegal acts, and confiscated 55 yuan of illegal gains .
-
China Resources Sanjiu Chairman Wang Chuncheng resigns
Time of Update: 2022-01-01
On December 4, China Resources Sanjiu issued an announcement stating that the company received a resignation report from the chairman of the board, Mr.
As of the date of this announcement, Wang Chuncheng does not hold the company's stock .
-
Stuximab introduced by BeiGene is approved to be marketed in China for the treatment of multicenter Casterman's disease
Time of Update: 2022-01-01
On December 2, the State Food and Drug Administration issued an announcement stating that it has recently passed the priority review and approval procedure to approve the import registration application of Stuximab (English name: Siltuximab for Injection) for the injection of rare disease drugs in urgent need of clinical use for human immunization.
-
Lingkang Pharmaceutical obtained approval for drug registration with piperacillin sodium and sulbactam sodium for injection
Time of Update: 2022-01-01
. Piperacillin sodium and sulbactam sodium for injection (4:1) Indications: suitable for moderate to severe infections caused by β-lactamase-producing bacteria that are resistant to piperacillin and sensitive to this product.
-
With the vigorous development of the biomedical industry, disposable systems will gradually replace stainless steel equipment
Time of Update: 2022-01-01
"Compared with traditional large-scale stainless steel bioreactors, the disposable system is more flexible, has a short construction period, low initial investment costs, and higher production capacity, which can accelerate the commercialization of biomedical companies .
-
Another imported rare disease drug is about to be launched in China
Time of Update: 2022-01-01
Recently, the National Medical Products Administration passed the priority review and approval procedure and approved the import registration application of Stuximab (English name: Siltuximab for Injection) for injection of rare disease drugs urgently needed in clinical use for human immunodeficiency virus (HIV) Adult patients with multicentric Castleman disease (MCD) who are negative and human herpesvirus type 8 (HHV-8) negative .
